Revive Rx LLC

FDA Regulatory Profile

Revive Rx LLC has 3 FDA recalls (2 Class I), 3 inspections, 0 510(k) clearances and 1 compliance action on record.

Latest recall
D-0511-2024 · Class I · Apr 20, 2024
Latest inspection
Feb 7, 2025 · OAI

Reviewing Revive Rx LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Revive Rx LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls3 (2 Class I)Nov 4, 2026 (checked Nov 8, 2026, unchanged)File dated Nov 3, 2026Current
510(k) clearances0Nov 8, 2026File dated Nov 2, 2026Current
Inspections3Nov 8, 2026Newest record Oct 28, 2026Current
Compliance actions1Nov 2, 2026Newest record Oct 29, 2026Current

Recent Recalls

NumberClassProductDate
D-0511-2024Class ITirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL Multi-dose vial, Rx only, This is a Compounded…Apr 20, 2024
D-0771-2023Class IITirzepatide 10 mg/0.5 mL Sterile Solution-2 mL Vial, Rx Only, For Sub-Q Use Only, Compounded Drug…May 11, 2023
D-0648-2022Class IHCG 6,000iu (lyo) Human Chorionic Gonadotropin Inj., For Sub-Q or IM Use Only, Not For IV Use, Vial…Feb 11, 2022

Recent FDA Inspections

DateSiteProductClassificationFEI
Feb 7, 2025Houston, TXDrugsOfficial Action Indicated (OAI)3016710945
May 4, 2022Houston, TXDrugsVoluntary Action Indicated (VAI)3016710945
Aug 6, 2021Houston, TXDrugsOfficial Action Indicated (OAI)3016710945

NAI means no objectionable conditions or practices were found during the inspection. VAI means objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action. OAI means regulatory and/or administrative actions are recommended.

FDA-Inspected Facilities

FacilityLocationInspectionsLatest
FEI 3016710945Houston, TX3Feb 7, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.